These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 22579789)

  • 1. Liver tumor-initiating cells as a therapeutic target for hepatocellular carcinoma.
    Lee TK; Cheung VC; Ng IO
    Cancer Lett; 2013 Sep; 338(1):101-9. PubMed ID: 22579789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver cancer stem cells: implications for a new therapeutic target.
    Lee TK; Castilho A; Ma S; Ng IO
    Liver Int; 2009 Aug; 29(7):955-65. PubMed ID: 19490415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biology of hepatic cancer stem cells.
    Tong CM; Ma S; Guan XY
    J Gastroenterol Hepatol; 2011 Aug; 26(8):1229-37. PubMed ID: 21557770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic modification of MiR-429 promotes liver tumour-initiating cell properties by targeting Rb binding protein 4.
    Li L; Tang J; Zhang B; Yang W; LiuGao M; Wang R; Tan Y; Fan J; Chang Y; Fu J; Jiang F; Chen C; Yang Y; Gu J; Wu D; Guo L; Cao D; Li H; Cao G; Wu M; Zhang MQ; Chen L; Wang H
    Gut; 2015 Jan; 64(1):156-67. PubMed ID: 24572141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The biological implication of cancer stem cells in hepatocellular carcinoma: a possible target for future therapy.
    Sukowati CH; Tiribelli C
    Expert Rev Gastroenterol Hepatol; 2013 Nov; 7(8):749-57. PubMed ID: 24161136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD24(+) liver tumor-initiating cells drive self-renewal and tumor initiation through STAT3-mediated NANOG regulation.
    Lee TK; Castilho A; Cheung VC; Tang KH; Ma S; Ng IO
    Cell Stem Cell; 2011 Jul; 9(1):50-63. PubMed ID: 21726833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysregulation of signaling pathways and putative biomarkers in liver cancer stem cells (Review).
    Song K; Wu J; Jiang C
    Oncol Rep; 2013 Jan; 29(1):3-12. PubMed ID: 23076400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncostatin m renders epithelial cell adhesion molecule-positive liver cancer stem cells sensitive to 5-Fluorouracil by inducing hepatocytic differentiation.
    Yamashita T; Honda M; Nio K; Nakamoto Y; Yamashita T; Takamura H; Tani T; Zen Y; Kaneko S
    Cancer Res; 2010 Jun; 70(11):4687-97. PubMed ID: 20484035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disulfiram eradicates tumor-initiating hepatocellular carcinoma cells in ROS-p38 MAPK pathway-dependent and -independent manners.
    Chiba T; Suzuki E; Yuki K; Zen Y; Oshima M; Miyagi S; Saraya A; Koide S; Motoyama T; Ogasawara S; Ooka Y; Tawada A; Nakatsura T; Hayashi T; Yamashita T; Kaneko S; Miyazaki M; Iwama A; Yokosuka O
    PLoS One; 2014; 9(1):e84807. PubMed ID: 24454751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anatomic pathology of hepatocellular carcinoma: impact on prognosis and response to therapy.
    Roskams T
    Clin Liver Dis; 2011 May; 15(2):245-59, vii-x. PubMed ID: 21689611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chinese herbal medicine-derived compounds for cancer therapy: a focus on hepatocellular carcinoma.
    Hu Y; Wang S; Wu X; Zhang J; Chen R; Chen M; Wang Y
    J Ethnopharmacol; 2013 Oct; 149(3):601-12. PubMed ID: 23916858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Granulin-epithelin precursor as a therapeutic target for hepatocellular carcinoma.
    Ho JC; Ip YC; Cheung ST; Lee YT; Chan KF; Wong SY; Fan ST
    Hepatology; 2008 May; 47(5):1524-32. PubMed ID: 18393387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Granulin-epithelin precursor and ATP-dependent binding cassette (ABC)B5 regulate liver cancer cell chemoresistance.
    Cheung ST; Cheung PF; Cheng CK; Wong NC; Fan ST
    Gastroenterology; 2011 Jan; 140(1):344-55. PubMed ID: 20682318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer-Associated Fibroblasts Regulate Tumor-Initiating Cell Plasticity in Hepatocellular Carcinoma through c-Met/FRA1/HEY1 Signaling.
    Lau EY; Lo J; Cheng BY; Ma MK; Lee JM; Ng JK; Chai S; Lin CH; Tsang SY; Ma S; Ng IO; Lee TK
    Cell Rep; 2016 May; 15(6):1175-89. PubMed ID: 27134167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human carbonyl reductase 1 upregulated by hypoxia renders resistance to apoptosis in hepatocellular carcinoma cells.
    Tak E; Lee S; Lee J; Rashid MA; Kim YW; Park JH; Park WS; Shokat KM; Ha J; Kim SS
    J Hepatol; 2011 Feb; 54(2):328-39. PubMed ID: 21056497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNA interference against granulin-epithelin precursor prevents hepatocellular carcinoma growth: its application as a therapeutic agent.
    Park MY; Park YS; Nam JH
    Int J Oncol; 2011 Oct; 39(4):853-61. PubMed ID: 21701774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer stem cell as a potential therapeutic target in hepatocellular carcinoma.
    Pang RW; Poon RT
    Curr Cancer Drug Targets; 2012 Nov; 12(9):1081-94. PubMed ID: 22873219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Granulin-epithelin precursor is an oncofetal protein defining hepatic cancer stem cells.
    Cheung PF; Cheng CK; Wong NC; Ho JC; Yip CW; Lui VC; Cheung AN; Fan ST; Cheung ST
    PLoS One; 2011; 6(12):e28246. PubMed ID: 22194816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Novel therapeutic strategies for treatment of hepatocellular carcinoma: targeting intervention on liver cancer stem cells].
    Li X; Luo Q; Song G
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2013 Aug; 30(4):894-8. PubMed ID: 24059077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lupeol targets liver tumor-initiating cells through phosphatase and tensin homolog modulation.
    Lee TK; Castilho A; Cheung VC; Tang KH; Ma S; Ng IO
    Hepatology; 2011 Jan; 53(1):160-70. PubMed ID: 20979057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.